Tumour inoculation site dependent induction of cachexia in mice bearing colon 26 carcinoma

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 764-769

  Matsumoto, T ^a,b   Fujimoto Ouchi, K ^a   Tamura, S ^a   Tanaka, Y ^a   Ishitsuka, H ^a  

^a NIPPON ROCHE RESEARCH CENTER   (Japan)

^b AGENE Research Institute   (Japan)

Author keywords

Cachexia; Colon 26; IL 6; Inoculation site; Malignancy

Indexed keywords

INTERLEUKIN 6;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CACHEXIA; CELL SHAPE; COLON CARCINOMA; HYPERCALCEMIA; HYPOGLYCEMIA; LIVER; MALE; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; BODY WEIGHT; CACHEXIA; CLONE CELLS; COLONIC NEOPLASMS; INTERLEUKIN-1; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MUSCLE, SKELETAL; SKIN; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033067136     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690123     Document Type: Article

References (24)

1. Arend WP, Joslin FG and Massoni RJ (1985) Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol 134: 3868-3875
2. Eda H, Tanaka Y and Ishitsuka H (1991) 5′-Deoxy-5-fluorouridine improves cachexia by a mechanism independent of its antiproliferative action in colon 26 adenocarcinoma-bearing mice. Cancer Chemother Pharmacol 29: 1-6
3. Fiers W (1991) Tumour necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett 285: 199-212
4. Fujimoto-Ouchi K, Tamura S, Mori K, Tanaka Y and Ishitsuka H (1995) Establishment and characterization of cachexia inducing and non-inducing clones of murine colon 26 carcinoma. Int J Cancer 61: 522-528
5. Gelin J, Moldawer LL, Lonnroth C, Sherry B, Chizonite R and Lundholm K (1991) Role of endogenous tumour necrosis factor a and interleukin 1 for experimental tumour growth and the development of cancer cachexia. Cancer Res 51: 415-421
6. Gitelman HJ (1967) An improved automated procedure for the determination of calcium in biological specimens. Anal Biochem 18: 521-531
7. Hsu SM, Raine L and Fanger H (1981) Use of avidin-biotin-peroxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580
8. Matthys P, Dijkmans R, Proost P, Van Damme J, Heremans H, Sobis H and Billiau A (1991a) Severe cachexia in mice inoculated with interferon-γ-producing tumour cells. Int J Cancer 49: 77-82
9. Matthys P, Heremans H, Opdenakker G and Billiau A (1991b) Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur J Cancer 27: 182-187
10. Moldawer LL, Georgieff M and Lundholm K (1987) Interleukin1, tumour necrosis factor-α (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol 7: 263-274
11. Mori M, Yamaguchi K, Honda S, Nagasaki K, Ueda M, Abe O and Abe K (1991) Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 51: 6656-6659
12. Nakajima M, Morikawa K, Fabra A, Bucana CD and Fidler IJ (1990) Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82: 1890-1898
13. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A and Socher SH (1987) Tumour secreting human TNF/cachectin induce cachexia in mice. Cell 50: 555-563
14. Steinkasserer A, Estaller C, Weiss EH and Sim RB (1992) Human interleukin-1 receptor antagonist is expressed in liver. FEBS Lett 310: 60-62
15. Stovroff MC, Fraker DL, Swedenborg JA and Norton JA (1988) Cachectin/tumour necrosis factor-α possible mediator of cancer cachexia in the rat. Cancer Res 48: 4567-4572
16. Strassmann G, Fong M, Kenney JS and Jacob CO (1992a) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89: 1681-1684
17. Strassmann G, Jacob CO, Evans R, Beall D and Fong M (1992b) Mechanisms of experimental cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J Immunol 148: 3674-3678
18. Strassmann G, Masui Y, Chizzonite R and Fong M (1993) Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumour. J Immunol 150: 2341-2345
19. Tamura S, Fujimoto K, Mori K, Endo M, Matsumoto T, Eda H, Tanaka Y, Ishitsuka H, Tokita H and Yamaguchi K (1995) Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft. Clin Cancer Res 1: 1353-1358
20. Tanaka Y, Eda H, Tanaka T, Udagawa T, Ishikawa T, Horii I, Ishitsuka H, Kataoka T and Taguchi T (1990) Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 50: 2290-2295
21. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A and Lowry SF (1988) Cachectin/tumour necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167: 1211-1227
22. Vidal-Vanaclocha F, Glaves D, Barbera-Guillem E and Weiss L (1991) Quantitative microscopy of mouse colon 26 cells growing in different metastatic sites. Br J Cancer 63: 748-752
23. Yoneda T, Alsina MA, Chavez JB, Bonewald L, Nishimura R and Mundy GR (1991) Evidence that tumour necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumour in nude mice. J Clin Invest 87: 977-985
24. Yoneda T, Nakai M, Moriyama K, Scott L, Ida N, Kunitomo T and Mundy GR (1993) Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. Cancer Res 53: 737-740